230 related articles for article (PubMed ID: 28626918)
1. Marinesco bodies and substantia nigra neuron density in Parkinson's disease.
Abbott RD; Nelson JS; Ross GW; Uyehara-Lock JH; Tanner CM; Masaki KH; Launer LJ; White LR; Petrovitch H
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):621-630. PubMed ID: 28626918
[TBL] [Abstract][Full Text] [Related]
2. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
[TBL] [Abstract][Full Text] [Related]
3. Bowel movement frequency in late-life and substantia nigra neuron density at death.
Petrovitch H; Abbott RD; Ross GW; Nelson J; Masaki KH; Tanner CM; Launer LJ; White LR
Mov Disord; 2009 Feb; 24(3):371-6. PubMed ID: 19006191
[TBL] [Abstract][Full Text] [Related]
4. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.
Ross GW; Petrovitch H; Abbott RD; Nelson J; Markesbery W; Davis D; Hardman J; Launer L; Masaki K; Tanner CM; White LR
Ann Neurol; 2004 Oct; 56(4):532-9. PubMed ID: 15389895
[TBL] [Abstract][Full Text] [Related]
5. Midlife milk consumption and substantia nigra neuron density at death.
Abbott RD; Ross GW; Petrovitch H; Masaki KH; Launer LJ; Nelson JS; White LR; Tanner CM
Neurology; 2016 Feb; 86(6):512-9. PubMed ID: 26658906
[TBL] [Abstract][Full Text] [Related]
6. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
7. Parallel enlargement of Marinesco bodies and nuclei and progressive deposition of p62 in pigmented neurons of the substantia nigra.
Amano R; Toru S; Yamane M; Kitagawa M; Hirokawa K; Uchihara T
Neuropathology; 2020 Aug; 40(4):328-335. PubMed ID: 32202001
[TBL] [Abstract][Full Text] [Related]
8. [DISTRIBUTION OF THE MARINESCO BODIES IN THE NEURONS OF HUMAN BRAIN SUBSTANTIA NIGRA].
Grigoriyev IP; Gusel'nikova VV; Sukhorukova YG; Korzhevskiy DE
Morfologiia; 2015; 148(5):28-31. PubMed ID: 26987214
[TBL] [Abstract][Full Text] [Related]
9. Increased synphilin-1 expression in human elderly brains with substantia nigra Marinesco bodies.
Krygowska-Wajs A; Lenda T; Adamek D; Moskała M; Kuter K; Kunz J; Smiałowska M; Ossowska K
Pharmacol Rep; 2008; 60(6):914-24. PubMed ID: 19211984
[TBL] [Abstract][Full Text] [Related]
10. A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease.
Ma SY; Rinne JO; Collan Y; Röyttä M; Rinne UK
J Neurol Sci; 1996 Sep; 140(1-2):40-5. PubMed ID: 8866425
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
12. Ageing and Parkinson's disease: substantia nigra regional selectivity.
Fearnley JM; Lees AJ
Brain; 1991 Oct; 114 ( Pt 5)():2283-301. PubMed ID: 1933245
[TBL] [Abstract][Full Text] [Related]
13. Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.
Ma SY; Röyttä M; Rinne JO; Collan Y; Rinne UK
J Neurol Sci; 1997 Oct; 151(1):83-7. PubMed ID: 9335015
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.
Brown DF; Dababo MA; Bigio EH; Risser RC; Eagan KP; Hladik CL; White CL
J Neuropathol Exp Neurol; 1998 Jan; 57(1):39-46. PubMed ID: 9600196
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
Tompkins MM; Basgall EJ; Zamrini E; Hill WD
Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
Camicioli R; Kaye J; Payami H; Ball MJ; Murdoch G
Dement Geriatr Cogn Disord; 1999; 10(6):437-41. PubMed ID: 10559556
[TBL] [Abstract][Full Text] [Related]
18. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
[TBL] [Abstract][Full Text] [Related]
19. GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration.
Liu Q; Chen J; Xue J; Zhou X; Tian Y; Xiao Q; Huang W; Pan Y; Zhou X; Li J; Zhao Y; Pan H; Wang Y; He R; Xiang Y; Tu T; Xu Q; Sun Q; Tan J; Yan X; Li J; Guo J; Shen L; Duan R; Tang B; Liu Z
Eur J Neurol; 2024 Feb; 31(2):e16145. PubMed ID: 37975799
[TBL] [Abstract][Full Text] [Related]
20. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
Pal GD; Ouyang B; Serrano G; Shill HA; Goetz C; Stebbins G; Metman LV; Driver-Dunckley E; Mehta SH; Caviness JN; Sabbagh MN; Adler CH; Beach TG;
Mov Disord; 2017 Feb; 32(2):274-277. PubMed ID: 27911008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
